Reminder: Invitation to Roche’s Virtual Neurology Investor Event Montag, 04. März 2024 - 14:02

We are pleased to invite investors and analysts to participate in our virtual event on Monday, 11 March 2024, highlighting key data presented at 2024 Muscular Dystrophy Association (MDA) and Alzheimer's & Parkinson's Diseases (AD/PD) conferences.

15:00 – 16:30 CET / 14:00 – 15:30 GMT

10:00 – 11:30 AM EDT / 07:00 – 08:30 AM PDT

The webinar will start with presentations, followed by a Q&A session (live access to the speakers). The slides will be available for download at 14:00 CET on the day of the event. >click here

Agenda

Welcome

Bruno Eschli, Head of Investor Relations

Neurology franchise update

Paulo Fontoura, Senior Vice President and Global Head of Neuroscience, Immunology, Ophthalmology, Cardiometabolic, Infectious and Rare Diseases Clinical Development

Review of key EMBARK data presented at MDA

Alex Murphy, Senior Clinical Director

Review of key trotinemab and prasinezumab data presented at AD/PD

Azad Bonni, MD, PhD, Senior Vice President and Global Head of Neuroscience & Rare Diseases, Roche Pharma Research & Early Development

Q&A

Access to virtual event (pre-registration required)

Please pre-register for our webinar here.*

Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.

A replay of the webinar will be available via > ir.roche.com

*privacy notice

Best regards,

Bruno Eschli
Head of Investor Relations

Loren Kalm

Head of Investor Relations, North America

Roche Investor Relations

Dr. Bruno Eschli

Phone: +41 61 68-75284

e-mail: bruno.eschli@roche.com

Dr. Sabine Borngräber

Phone: +41 61 68-88027

e-mail: sabine.borngraeber@roche.com

Dr. Birgit Masjost

Phone: +41 61 68-84814

e-mail: birgit.masjost@roche.com

Investor Relations North America

Loren Kalm

Phone: +1 650 225 3217

e-mail: kalm.loren@gene.com